Author

Ranko Gacesa

LONG-TERM TYPE 1 DIABETES AND ITS COMPLICATIONS ARE ASSOCIATED TO CHANGES IN GUT MICROBIOTA
LONG-TERM TYPE 1 DIABETES AND ITS COMPLICATIONS ARE ASSOCIATED TO CHANGES IN GUT MICROBIOTA

Ranko Gacesa  et al.

GUT MICROBIOME COMPOSITION AND FUNCTION ARE LINKED TO THE DEVELOPMENT OF (PRE)CANCEROUS COLONIC LESIONS IN A PROSPECTIVE FOLLOW UP STUDY OF THE DUTCH MICROBIOME PROJECT
GUT MICROBIOME COMPOSITION AND FUNCTION ARE LINKED TO THE DEVELOPMENT OF (PRE)CANCEROUS COLONIC LESIONS IN A PROSPECTIVE FOLLOW UP STUDY OF THE DUTCH MICROBIOME PROJECT

Ranko Gacesa  et al.

THE DUTCH MICROBIOME PROJECT: DEFINING THE (UN)HEALTHY GUT MICROBIOME AND ITS DETERMINING FACTORS IN 9000 METAGENOMES
THE DUTCH MICROBIOME PROJECT: DEFINING THE (UN)HEALTHY GUT MICROBIOME AND ITS DETERMINING FACTORS IN 9000 METAGENOMES

GUT MICROBIOME COMPOSITION AND FUNCTION ARE LINKED TO THE DEVELOPMENT OF (PRE)CANCEROUS COLONIC LESIONS IN A PROSPECTIVE FOLLOW UP STUDY OF THE DUTCH MICROBIOME PROJECT
GUT MICROBIOME COMPOSITION AND FUNCTION ARE LINKED TO THE DEVELOPMENT OF (PRE)CANCEROUS COLONIC LESIONS IN A PROSPECTIVE FOLLOW UP STUDY OF THE DUTCH MICROBIOME PROJECT

LONG-TERM TYPE 1 DIABETES AND ITS COMPLICATIONS ARE ASSOCIATED TO CHANGES IN GUT MICROBIOTA
LONG-TERM TYPE 1 DIABETES AND ITS COMPLICATIONS ARE ASSOCIATED TO CHANGES IN GUT MICROBIOTA

THE DUTCH MICROBIOME PROJECT: DEFINING THE (UN)HEALTHY GUT MICROBIOME AND ITS DETERMINING FACTORS IN 9000 METAGENOMES
THE DUTCH MICROBIOME PROJECT: DEFINING THE (UN)HEALTHY GUT MICROBIOME AND ITS DETERMINING FACTORS IN 9000 METAGENOMES

Ranko Gacesa  et al.

DISTINCT MUCOSAL HOST-MICROBE INTERACTIONS IN RELATION TO CLINICAL PHENOTYPES IN INFLAMMATORY BOWEL DISEASE
DISTINCT MUCOSAL HOST-MICROBE INTERACTIONS IN RELATION TO CLINICAL PHENOTYPES IN INFLAMMATORY BOWEL DISEASE

Ranko Gacesa  et al.

THE GUT MICROBIOME OF HEALTHY SIBLINGS OF INFLAMMATORY BOWEL DISEASE (IBD) TWINS DISPLAYS IBD SIGNATURES
THE GUT MICROBIOME OF HEALTHY SIBLINGS OF INFLAMMATORY BOWEL DISEASE (IBD) TWINS DISPLAYS IBD SIGNATURES

Ranko Gacesa  et al.

DISRUPTION OF THE GUT MICROBIOME IN RENAL TRANSPLANT RECIPIENTS: RESULTS FROM THE TRANSPLANTLINES COHORT AND BIOBANK STUDY
DISRUPTION OF THE GUT MICROBIOME IN RENAL TRANSPLANT RECIPIENTS: RESULTS FROM THE TRANSPLANTLINES COHORT AND BIOBANK STUDY

Ranko Gacesa  et al.

THE ALTERATION OF GUT MICROBIOME IN LIVER TRANSPLANTATION: FIRST RESULTS FROM THE TRANSPLANTLINES BIOBANK AND COHORT STUDY
THE ALTERATION OF GUT MICROBIOME IN LIVER TRANSPLANTATION: FIRST RESULTS FROM THE TRANSPLANTLINES BIOBANK AND COHORT STUDY

Ranko Gacesa  et al.

DIETARY PATTERNS ARE REFLECTED IN THE PLASMA INFLAMMATORY PROTEOME OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE
DIETARY PATTERNS ARE REFLECTED IN THE PLASMA INFLAMMATORY PROTEOME OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Ranko Gacesa  et al.

THE GUT MICROBIOME FOLLOW-UP ANALYSIS REVEALS ITS FINGERPRINT POTENTIAL AND CLINICAL RELEVANCE
THE GUT MICROBIOME FOLLOW-UP ANALYSIS REVEALS ITS FINGERPRINT POTENTIAL AND CLINICAL RELEVANCE

Ranko Gacesa  et al.

LIFELINES NEXT PILOT: EARLY DEVELOPMENT OF THE GUT BACTERIOME AND VIROME AND THEIR INTERACTIONS
LIFELINES NEXT PILOT: EARLY DEVELOPMENT OF THE GUT BACTERIOME AND VIROME AND THEIR INTERACTIONS

Ranko Gacesa  et al.

GUT MICROBIAL CHANGES IN RESPONSE TO VEDOLIZUMAB TREATMENT IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
GUT MICROBIAL CHANGES IN RESPONSE TO VEDOLIZUMAB TREATMENT IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Ranko Gacesa  et al.

HOST-GENETICS, DYSBIOSIS AND CLINICAL HISTORY EXPLAINS FECAL METABOLIC ALTERATIONS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
HOST-GENETICS, DYSBIOSIS AND CLINICAL HISTORY EXPLAINS FECAL METABOLIC ALTERATIONS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Ranko Gacesa  et al.

Item 1 - 15 / 15
1